When was NeuroStar founded?

NeuroStar was founded in 2003 and raised its 1st funding round 6 years after it was founded.

Where is NeuroStar located?

NeuroStar is headquartered in Malvern, United States. It is registered at Malvern, Pennsylvania.

How many employees does NeuroStar have?

As of May 31, 2026, the latest employee count at NeuroStar is 211.

Is NeuroStar a funded company?

NeuroStar is a funded company, having raised a total of $119M across 7 funding rounds to date. The company's 1st funding round was a $***** Series C round, raised on Aug 21, 2009.

When was the latest funding round of NeuroStar?

NeuroStar's latest funding was a $***** Conventional Debt round on Mar 02, 2020, with participation from 1 investor. Its primary sector is Neurology. In United States, the Neurology sector has seen $3.1B in funding in 2026 to date.

What is the annual revenue of NeuroStar?

Annual revenue of NeuroStar is between $100M and $500M as on Dec 31, 2025

Where does NeuroStar rank among its competitors?

NeuroStar ranks 1st amongst 17 active competitors, of which 6 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Magnus, which secured $11.6M in Aug, 2025.

Who are the top competitors of NeuroStar?

NeuroStar's top competitors include Flow Neuroscience, Neuronetics and Magnus Medical. Among them, Magnus secured the most recent funding round in August, 2025.

NeuroStar - 2026 Company Profile, Funding, Competitors & Financials

NeuroStar is a public company based in Malvern (United States), founded in 2003. It operates as a Provider of a non-drug non-invasive therapeutic devices for neurorehabilitation. NeuroStar has raised $119M in funding from Ascension Ventures. The company has 17 active competitors, including 6 funded and 3 that have exited. Its top competitors include companies like Flow Neuroscience, Neuronetics and Magnus Medical.

Company Details

Provider of a non-drug non-invasive therapeutic devices for neurorehabilitation. It focuses on the therapeutic applications of the MRI-strength pulsed magnetic field for treating disorders of the central nervous system. The TMS Therapy is an FDA cleared device used for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.

Website: neurostar.com
Social
Phone Number: +1 **********
Part Of
Registered Address: Malvern, Pennsylvania

Key Metrics

Founded Year

2003

Location

Malvern, United States

Stage

Public

Total Funding

$119M in 7 rounds

Latest Funding Round

Conventional Debt, Mar 02, 2020, $*****

Investors

Ascension Ventures & 15 more

Ranked

1^st among 17 active competitors

Annual Revenue

$100M - $500M as on Dec 31, 2025

Employee Count

211 as on May 31, 2026

Similar Companies

Flow Neuroscience & 15 more

Exit Details

Public

View NeuroStar's full profile

NeuroStar is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Neuronetics, Inc. CIN: 331051425 , United States, Active		$100M - $500M (As on Dec 31, 2025)	312 (As on Dec 31, 2023)	-

NeuroStar got listed on Jun 28, 2018.

Click here to take a look at NeuroStar's IPO in detail

NeuroStar has raised a total funding of $119M over 7 rounds. Its first funding round was on Aug 21, 2009. Its latest funding round was a Conventional Debt round on Mar 02, 2020 for $*****. 1 investor participated in its latest round. NeuroStar has 16 institutional investors.

Here is the list of recent funding rounds of NeuroStar:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 02, 2020	8858701	Conventional Debt	2457407	9303547	6086097	8776076
Jun 13, 2017	8855856	Series G	3867658	9535363	3884287	Accuitive Medical Ventures & 10 more
May 06, 2015	3057799	Series C	2752940	3705439	7732708	8417383

Access funding benchmarks and valuations. Sign up today!

View details of NeuroStar's funding rounds and investors

NeuroStar's employee count trend

NeuroStar has 211 employees as of May 26. Here is NeuroStar's employee count trend over the years:

Uncover NeuroStar's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NeuroStar include Flow Neuroscience, Neuronetics and Magnus Medical. Here is the list of Top 10 competitors of NeuroStar, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	NeuroStar 2003, Malvern (United States), Public	Provider of a non-drug non-invasive therapeutic devices for neurorehabilitation	$119M	Quaker Partners Management, Industry Ventures ... & 14 others	70/100
2nd	Flow Neuroscience 2016, Malmo (Sweden), Series A	Provider of a wearable device for stress and anxiety management	$11.9M	Khosla Ventures, HAX & 6 others	61/100
3rd	Neuronetics 2001, Malvern (United States), Series G	Transforming neurohealth with innovative, non-drug TMS therapy for mental health	$178M	Polaris Partners, Pfizer Venture Investments ... & 16 others	60/100
4th	Magnus Medical 2017, Burlingame (United States), Series B	Provider of non invasive neuromodulation system for depression treatment	$65.3M	JAZZ Venture Partners, Red Tree Venture Capital ... & 1 others	54/100
5th	Magstim 1990, Whitland (United Kingdom), Acquired	Developer of EEG, TMS, and tDCS neurotechnology solutions	$32.1M	Finance Wales, Telegraph Hill Partners & 1 others	51/100
6th	Brainsway 2003, Jerusalem (Israel), Public	Develoepr of noninvasive neurostimulation treatments for mental health disorders	-	Valor Equity Partners, Shavit Capital & 4 others	46/100
7th	Soterix Medical 2008, New York City (United States), Funding Raised	Neuromodulation and brain stimulation technology for neuropsychiatric and neurological disorders	-	NINDS, HHS	41/100
8th	Magnus 2020, Burlingame (United States), Series C	Provider of transcranial magnetic stimulation therapy for major depressive disorder	$49M	HHS, Military Health	39/100
9th	Tonic 1991, Farum (Denmark), Unfunded	Manufacturer of transcranial magnetic stimulation (TMS) systems for research and treatment	-	-	39/100
10th	Neuroprex 2012, Santa Clara (United States), Seed	Developer of a wearable device to modulate tissue for neurological diseases	$50K	National Science Foundation, EIC Fund & 1 others	32/100